School of Medicine

Showing 11-20 of 55 Results

  • Rajib Ahmed

    Rajib Ahmed

    Postdoctoral Research Fellow, Radiology

    Bio Dr. Rajib Ahmed working as a postdoc fellow at Stanford University School of Medicine, Canary Center at Stanford for Cancer Early Detection. His research focus on micro- and nano-technologies based biomedical optical devices.

    Rajib received his B.Sc. and M.Sc. degree at the department of applied physics electronics and communication engineering in 2010 and 2012 from University of Dhaka (Bangladesh), and also studied two-year double degree M.Sc. as a Erasmus mundus student at MAsters on Photonic NETworks Engineering (MAPNET) on in Scuola Superiore Sant’Anna (Italy), Aston University (UK), and Technische Univeraitat Berlin (Germany) in 2013-2014. He received his Ph.D. degree on laser based nanofabrication from school of engineering, University of Birmingham (UK) in 2018. Upon the completion of his Ph.D. studies, Rajib started working as a postdoctoral research fellow at Stanford University School of Medicine in 2018.

    Rajib has published his research work in the most prestigious journals (more than 40), including ACS Nano, Light: Science & Applications, Advanced Optical Materials, Advanced Healthcare Materials, Scientific Reports, Nanoscale, ACS Photonics, Optics Express, Optics Letter, Applied Physics Letter, etc. Besides his research publications, he has contributed to the publication of 4 book chapters and also working as a scientific journal editors and reviewers. His research findings have been presented in national and international conferences.

  • Kristen Aiemjoy

    Kristen Aiemjoy

    Postdoctoral Research Fellow, Infectious Diseases

    Bio Dr. Aiemjoy is an infectious disease epidemiologist with interests in diarrheal disease, measurement, diagnostics, and sero-epidemiology. She is currently working on evaluating serological markers for Salmonella Typhi and Paratyphi infection as part of the Sero-Epidemiology and Environmental Surveillance (SEES) study in Nepal, Pakistan and Bangladesh.

  • Vincent Michael Alford

    Vincent Michael Alford

    Postdoctoral Research Fellow, Stem Cell Biology and Regenerative Medicine

    Current Research and Scholarly Interests My interest in science and research was fostered at a young age after losing a family member to colorectal cancer. At that young age, it was made apparent to me that cancer remains poorly understood which is reflected in the total lack of target-specific treatment regiments available to this patient population. This disparity in patient care is what inspired me to pursue a Ph.D in Molecular and Cellular Pharmacology at Stony Brook University (SBU). During my time at SBU, my dissertation research focused on the development of a standard approach for rational drug design against the functional activity of individual matrix metalloproteinases (MMPs). Results from this work led to the successful development of the first small molecule inhibitor specifically targeting the hemopexin domain of MMP-9. Additionally, I was also given the opportunity to assist in the development of a cell based High-Throughput Screen assay for the identification of small molecules with activity against cancer cell invasion.

    After obtaining my Ph.D, I pursued a postdoctoral scholar position at Stanford University within the Institute of Stem Cell Biology and Regenerative Medicine. Currently, my projects have slowly become broader and more focused around protein chemistry. More specifically, my research interest lies in identifying protein targets or cell populations responsible for chronic illnesses such as Triple Negative Breast Cancer and Alzheimer’s disease. After identifying the target, my passion lies in understanding the biological function of said target in various biological signaling cascades and cell niche population maintenance. Another area I specialize in is assigning function to the various domains of individual proteins and prioritizing drug development against the most promising targets. Upon identification of the target and validation of the domains responsible for protein activity- it becomes my mission to develop specific inhibitors against them. To this end, I use techniques such as protein mutagenesis, expression, and purification systems in addition to x-ray crystallography and chemical-protein structure activity relationships to understand, rationally design, and optimize these small molecule inhibitors for potential use in clinical trials.

  • Md Khadem Ali

    Md Khadem Ali

    Postdoctoral Research Fellow, Pulmonary and Critical Care Medicine

    Bio Dr MK Ali is a self-motivated and ambitious immunology and microbiology research scientist specialized in asthma, IPF, PH, and respiratory infectious disease. His academic and research training across 4 nations and 3 continents has given him skills in in vitro and in vivo disease modeling, airway/tissue remodeling, fibrosis, biomarker discovery, gene editing. His longer-term goal is to discover novel drug for unmet medical needs in critical respiratory diseases.

    Summary of Qualifications:
    • Proven track record of critical scientific thinking, multi-tasking ability, and strong leadership and communication skills with 8 years of research experience in immunology and microbiology as evidenced in 12 peer reviewed publications (Citations 230, H index 6) and 24 conference papers
    • Achieved 12 awards and scholarships
    • Reviewer for 4 international scientific journals, member of 12 scientific associations
    • Mentored 5 undergraduate and 1 junior PhD students, demonstrated immunology and microbiology lab course for 3 years
    • Proven first-hand experience handling and working with mice, rats and rabbits; experience conducting survival surgeries, experiments, drug treatments
    • Extensive first-hand experience on murine models of asthma, IPF, COPD, PH and respiratory infectious diseases; strong experience in airway/tissue remodeling, airway/lung inflammation, emphysema, collagen deposition around airways and lung tissues, lung function, FACS, immune cells phenotypic characterization, in vivo evaluation of gene-based or therapeutics
    • First-hand strong experience on handling and production of Haemophilus, Pseudomonas, Chlamydia respiratory infection, bacterial recovery from blood, BAL fluid, and lung
    • Extensive experience with primary lung epithelial, fibroblast, and endothelial cell and cardiac fibroblast culture, 10 cell lines culture, in vitro disease models, cytotoxic assays, cell proliferation, apoptosis, cytokines detection
    • First-hand strong experience on CRISPR/shRNA/siRNA-based gene silencing techniques
    • Proficiency with molecular cloning, manipulation, viral vectors, virus production, bacterial culture, transformation, protein expression, isolation, and purification
    • Proven first-hand experience with ELISA, westernblot, phosphorylations; histochemical, immunohistochemical techniques (light, fluorescence, confocal microscopy), qPCR, In Situ hybridization, RNAscope, RNA-seq
    • Expertise in bioinformatics tools such as Gene Trail, Go annotations and KEGG pathways, Panther, MGI, DAVID, STRING network analysis